|

AHB-137 Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 2: 5

Top Sponsors

  • Ausper Biopharma Co., Ltd.3
  • AusperBio Therapeutics Inc.2

Indications

Other4 trials

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2
A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
Phase 2
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
Phase 2
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Phase 2

Palo Alto, California1 trial

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

Stanford University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.